ผลงานวิจัยตีพิมพ์ปี 2014

1. Inflammatory and fibrotic proteins proteomically identified as key protein constituents in urine and stone matrix of patients with kidney calculi

Boonla, C., Tosukhowong, P., Spittau, B., Schlosser, A., Pimratana, C., Krieglstein, K.

ClinicaChimicaActa.2014;429:81-89.

2. Calcium oxalate crystallization index (COCI): An alternative method for distinguishing nephrolithiasis patients from healthy individuals

Yang, B., Dissayabutra, T., Ungjaroenwathana, W., Tosukhowong, P., Srisa-Art, M., Supaprom, T., Insin, N., Boonla, C.

Annals of Clinical and Laboratory Science.2014;44(3):262-271.

3. Increased oxidative DNA damage seen in renalbiopsies adjacent stones in patients with nephrolithiasis.

Kittikowit, W., Waiwijit, U., Boonla, C., Ruangvejvorachai, P., Pimratana, C., Predanon, C., Ratchanon, S., Tosukhowong, P.

Urolithiasis. 2014Oct;42(5):387-94.
ผลงานวิจัยตีพิมพ์ปี 2013

1. Oxidative stress induces hypomethylation of LINE-1 and hypermethylation of the RUNX3 promoter in a bladder cancer cell line.

Wongpaiboonwattana W, Tosukhowong P, Dissayabutra T, Mutirangura A, Boonla C.

Asian Pacific Journal of Cancer Prevention. 2013;14(6):3773-3778.

2. Increased intrarenal expression of sodium-dicarboxylate cotransporter-1 in nephrolithiasis patients with acidic urine pH.

Chuaypen N, Boonla C, Dissayabutra T, Predanon C, Ruangvejvorachai P, Waiwijit U, Tosukhowong P.

Asian Biomedicine. 2013;7(4):571-577.
ผลงานวิจัยตีพิมพ์ปี 2008-2012

1. Long interspersed nuclear element-1 hypomethylation and oxidative stress: correlation and bladder cancer diagnostic potential .

Patchsung M, Boonla C, Amnattrakul P, Dissayabutra T, Mutirangura A, Tosukhowong P.

PLoS One. 2012;7(5):e37009. doi: 10.1371/journal.pone.0037009. Epub 2012 May 15.

2. Fibrosis and evidence for epithelial-mesenchymal transition in the kidneys of patients with staghorn calculi.

Boonla C., Krieglstein K., Bovornpadungkitti S., Strutz F., Spittau B., Predanon C., Tosukhowong P.

BJU Int. 2011 Oct;108(8):1336-45.

3. Lithogenic activity and clinical relevance of lipids extracted from urines and stones of nephrolithiasis patients.

Boonla C, Youngjermchan P, Pumpaisanchai S, Tungsanga K, Tosukhowong P.

Urol Res. 2011 Feb;39(1):9-19.

4. Effects of lifestyle modification on oxidized LDL, reactive oxygen species production and endothelial cell viability in patients with coronary artery disease.

Srimahachota S, Wunsuwan R, Siritantikorn A, Boonla C, Chaiwongkarjohn S, Tosukhowong P.

Clin Biochem. 2010 Jul;43(10-11):858-62.

5. Citraturic, alkalinizing and antioxidative effects of limeade-based regimen in nephrolithiasis patients.

Tosukhowong P, Yachantha C, Sasivongsbhakdi T, Ratchanon S, Chaisawasdi S, Boonla C, Tungsanga K.

Urol Res. 2008 Aug;36(3-4):149-55.

6. Messenger RNA expression of monocyte chemoattractant protein-1 and interleukin-6 in stone-containing kidneys.

Boonla C, Hunapathed C, Bovornpadungkitti S, Poonpirome K, Tungsanga K, Sampatanukul P, Tosukhowong P.

BJU Int. 2008 May;101(9):1170-7.

7. Renal impairment and Stone risk in inhabitants environmentally exposed to cadmium in Mae Sot District of Tak Province, Thailand.

Tosukhowong P., Boonla C., Prapunwattana P., Supapong S., Tungsanga K., Mahasakpun P.

Asian Biomedicine. 2008;2(1):59-66.